Employers will likely to allow remote work after the availability of COVID-19 vaccine, according to a recent Gartner survey of 130 HR leaders on Dec 9.
Survey results indicate that 90% of respondents plan to allow employees to work remotely at least part of the time even after the COVID-19 vaccine is widely adopted.
In addition, 65% of respondents reported that their organization will continue to offer employees flexibility on when they work.
- 109 HR leaders who responded to Gartner’s survey predict that about 50% of the workforce will want to return to the workplace – at least part time – once a vaccine is made widely available.
- 62% of 118 HR leaders surveyed reported that they are planning to continue all safety measures they have put in place once a COVID-19 vaccine is available.
- Nearly one-third of respondents noted they would no longer require masks in the workplace nor enforce social distancing in high-traffic areas.
“Right now, organisations are considering different policies for employees who receive the vaccine and those who do not,” said Elisabeth Joyce, vice president of advisory in the Gartner HR practice. “What is most critical is that HR leaders are making these decisions with the expectation that they may need to course correct as we learn more.”
How firms might maintain health and safety of workforce
As different countries are currently experiencing a COVID-19 resurgence, requiring employers to take action to maintain the health and safety of their workforce.
- Among 136 HR leaders surveyed, 46% said their organisation has already, or will, shut down offices that had previously been reopened
- 37% reported extending new benefits to employees, such as childcare assistance and additional sick leave.
- When a COVID-19 vaccine becomes available, 60% of 116 HR leaders surveyed said they will encourage employees to get vaccinated, but it will not be required.
- 60% of respondents reported they will provide resources to employees on where and how to get vaccinated
- 44% said they plan to cover or subsidise the costs of the vaccine for employees.